USPTO 2015–2025 USPTO PatentsView Foreign Corporation

RaySearch Laboratories AB

USPTO PatentsView assignee record - 57 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Raysearch ranks #5,975 of 49,997 tracked US assignees by granted-patent volume, with 57 patents across 11 technology areas.

#5,975
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.1/100)
13.8
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5975 · Foreign Corporation #5,975 · 57 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 57 grants
  • UPPER-Q #5,975/49,997
  • PHOTO-FINISH Pangu BioPharma
  • CPC-FOCUS A61N · 11 areas
  • INNOV-PAR 40.1/100
  • CLAIMS-RICH 13.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pangu BioPharma Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Raysearch’s 40.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Raysearch

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Raysearch's Innovation Score is 40.1/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Raysearch?

Each dot is one of Raysearch’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Raysearch’s own 13.8 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Raysearch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 56.957.057.05757.057.057.1 12141618 Granted patents (volume) Avg claims / patent Pangu BioPharma Limited - 57, 12.58Pangu BiopharmaPoly-Med, Inc. - 57, 16.12Poly-medProduction Resource Group, L.L.C. - 57, 15.3Production Resour…Quantenna Communications, Inc. - 57, 16.18Quantenna Communi…Rhode Island Hospital - 57, 14.51Rhode Island Hosp…Robin Systems, Inc. - 57, 17.58Robin SystemsSchuler Pressen GMBH - 57, 14.79Schuler PressenShandong NEW Beiyang Information Technology Co., Ltd. - 57, 14.39Shandong NEW Beiy…RaySearch Laboratories AB - 57, 13.79Raysearch Laborat…
Raysearch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Raysearch's grants concentrate

RaySearch Laboratories AB is a focused PatentsView assignee: 11 CPC subclasses with 91.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (9 grants) versus a trough of 2 in 2016. By volume, Raysearch sits between Pangu BioPharma Limited and Shandong NEW Beiyang Information Technology Co., Ltd..

Raysearch's three-year grant acceleration

From 2019–2021 to 2022–2024, RaySearch Laboratories AB moved from 24 to 22 grants (0.92x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at RaySearch's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows RaySearch holds 57 patents at rank #5,973, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near RaySearch

By rank, the assignees closest to #5,973 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in RaySearch's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for RaySearch, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), RaySearch ranks #71 of 1,943 assignees by patent count in that subclass.

Raysearch's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
RaySearch Laboratories AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 3.5%
2017 2 3.5%
2018 2 3.5%
2019 7 12.3%
2020 8 14.0%
2021 9 15.8%
2022 8 14.0%
2023 8 14.0%
2024 6 10.5%
2025partial year 5 8.8%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

RaySearch Laboratories AB's patent record in context - here's where to go next.

  • RaySearch Laboratories AB's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 91.2% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #5,975 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare RaySearch Laboratories AB against Pangu BioPharma Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.